LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival

被引:22
作者
Liang, Meng [1 ]
Wang, Linlin [2 ]
Cao, Chuanhua [3 ]
Song, Shimao [1 ]
Wu, Feng [1 ]
机构
[1] Hubei Univ Med, Taihe Hosp, Dept Oncol, 32 South Renmin Rd, Shiyan 442000, Hubei, Peoples R China
[2] Hubei Univ Med, Renmin Hosp, Dept Radiol, Shiyan 442000, Hubei, Peoples R China
[3] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Affiliated Hosp, Dept Oncol, Xiangyang 441021, Hubei, Peoples R China
关键词
SNHG10; miR-21; NSCLC; Methylation; PROLIFERATION; BIOMARKER; THERAPY;
D O I
10.1186/s12890-020-01281-w
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background LncRNA SNHG10 has been reported to be an oncogenic lncRNA in liver cancer. However, its roles in non-small cell lung cancer (NSCLC) remains unknown. Methods Tumor and paired non-tumor tissues were harvested from 62 NSCLC patients. RT-qPCR was used to detect the expression of SNHG10 and miR-21 in tissues. Overexpression experiments were used to evaluate the interaction between SNHG10 and miR-21 in NSCLC cells. CCK-8 assay was used to detect the cell proliferation. Results We observed the expression of SNHG10 was down-regulated in non-small cell lung cancer (NSCLC) compared with that in non-tumor tissues. Moreover, we found that high expression levels of SNHG10 predicted favorable survival of NSCLC patients, and the expression of miR-21 were increased in NSCLC and inversely correlated with SNHG10 expression. In NSCLC cells, overexpression of SNHG10 resulted in increased miR-21 gene methylation and decreased miR-21 expression. Moreover, overexpression of SNHG10 attenuated the enhancing effect of miR-21 overexpression on cell proliferation. Conclusions SNHG10 may involve in NSCLC cell proliferation by regulating the miR-21 gene methylation.
引用
收藏
页数:6
相关论文
共 50 条
[31]   High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer [J].
Lu, Jianjun ;
Wang, Yanhong ;
Yan, Miansheng ;
Feng, Pinning ;
Yuan, Linjing ;
Cai, Yuesu ;
Xia, Xin ;
Liu, Min ;
Luo, Jinmei ;
Li, Laisheng .
ONCOTARGET, 2016, 7 (27) :41758-41766
[32]   Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients [J].
Liao, Li ;
Yu, Huajian ;
Ge, Mengxi ;
Zhan, Qiong ;
Huang, Ruofan ;
Ji, Xiaoyu ;
Liang, Xiaohua ;
Zhou, Xinli .
THORACIC CANCER, 2019, 10 (05) :1203-1212
[33]   LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity [J].
She, Kelin ;
He, Shushuai ;
Lu, Xiao ;
Yu, Shaoqi ;
Li, Mengna ;
Xiong, Wei ;
Zhou, Ming .
JOURNAL OF THORACIC DISEASE, 2023, 15 (01) :155-+
[34]   Metallothionein IF and 2A overexpression predicts poor outcome of non-small cell lung cancer patients [J].
Werynska, Bozena ;
Pula, Bartosz ;
Muszczynska-Bernhard, Beata ;
Gomulkiewicz, Agnieszka ;
Piotrowska, Aleksandra ;
Prus, Robert ;
Podhorska-Okolow, Marzena ;
Jankowska, Renata ;
Dziegiel, Piotr .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) :301-308
[35]   Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer [J].
Liao, Yunfei ;
Gu, Jie ;
Wu, Yongbing ;
Long, Xiang ;
Ge, Di ;
Xu, Jianjun ;
Ding, Jianyong .
ONCOLOGY LETTERS, 2016, 11 (06) :3753-3760
[36]   High Sam68 expression predicts poor prognosis in non-small cell lung cancer [J].
Z. Zhang ;
Y. Xu ;
N. Sun ;
M. Zhang ;
J. Xie ;
Z. Jiang .
Clinical and Translational Oncology, 2014, 16 :886-891
[37]   A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer [J].
Lu, Ping ;
Ma, Yifei ;
Kai, Jindan ;
Wang, Jun ;
Yin, Zhucheng ;
Xu, Hongli ;
Li, Xinying ;
Liang, Xin ;
Wei, Shaozhong ;
Liang, Xinjun .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
[38]   BLACAT1 predicts poor prognosis and serves as oncogenic lncRNA in small-cell lung cancer [J].
Chen, Weiwei ;
Hang, Ye ;
Xu, Weiwei ;
Wu, Jixiang ;
Chen, Longyun ;
Chen, Jinzhong ;
Mao, Yixiang ;
Song, Jin ;
Song, Jianxiang ;
Wang, Hanhua .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (02) :2540-2546
[39]   Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival [J].
Zhou, Ji ;
Bi, Hui ;
Zhan, Ping ;
Chang, Cunjie ;
Xu, Chunhua ;
Huang, Xiaojing ;
Yu, Like ;
Yao, Xin ;
Yan, Jun .
TUMOR BIOLOGY, 2014, 35 (10) :9777-9785
[40]   Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients [J].
Zhang, Xiupeng ;
Cai, Lin ;
Zhou, Haijing ;
Liu, Yang ;
Fan, Chuifeng ;
Wang, Liang ;
Li, Ailin ;
Miao, Yuan ;
Li, Qingchang ;
Qiu, Xueshan ;
Wang, Enhua .
MOLECULAR CARCINOGENESIS, 2017, 56 (12) :2558-2565